Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

被引：0
|
作者：
Marco Pozzi
Dario Cattaneo
Sara Baldelli
Serena Fucile
Annalisa Capuano
Carmela Bravaccio
Liberata Sportiello
Silvana Bertella
Fabiana Auricchio
Renato Bernardini
Carmen Ferrajolo
Giuseppe Guastella
Elisa Mani
Carla Carnovale
Simone Pisano
Concetta Rafaniello
Maria Pia Riccio
Renata Rizzo
Maria Grazia Scuderi
Serena Sperandeo
Laura Villa
Antonio Pascotto
Massimo Molteni
Francesco Rossi
Sonia Radice
Emilio Clementi
机构：
[1] Scientific Institute IRCCS Eugenio Medea,Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences L. Sacco, L. Sacco University Hospital
[2] Università di Milano,Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine
[3] Second University of Naples,Department of Translational Medical Sciences
[4] University Federico II of Naples,Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, School of Medicine
[5] University of Catania,Department of Mental and Physical Health and Preventive Medicine, Child and Adolescent Psychiatry Division
[6] Second University of Naples,Child and Adolescent Neuropsychiatry, Department of Medical and Paediatric Sciences, School of Medicine
[7] University of Catania,Unit of Clinical Pharmacology, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital
[8] Università di Milano,undefined
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Therapeutic drug monitoring; Pharmacokinetics; Risperidone; Aripiprazole; Second-generation antipsychotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 293
页数：8
相关论文
共 50 条
  • [31] Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study
    Laundon, Walter
    Muzyk, Andrew J.
    Gagliardi, Jane P.
    Christopher, Eric J.
    Rothrock-Christian, Tracie
    Jiang, Wei
    GENERAL HOSPITAL PSYCHIATRY, 2012, 34 (04) : 380 - 384
  • [32] Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study
    Gruender, Gerhard
    Heinze, Martin
    Cordes, Joachim
    Muehlbauer, Bernd
    Juckel, Georg
    Schulz, Constanze
    Ruether, Eckart
    Timm, Juergen
    LANCET PSYCHIATRY, 2016, 3 (08): : 717 - 729
  • [33] Predictors of weight gain after six months of treatment with second-generation antipsychotics in pediatric and adult patients
    Diaz-Caneja, C. M.
    Pina-Camacho, L.
    Fraguas, D.
    Gonzalez-Pinto, A.
    Rodriguez-Jimenez, R.
    Garcia, A.
    Sanjuan, J.
    Saiz, P.
    Arias, B.
    Corripio, I.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S710 - S711
  • [34] A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents
    Calafiore, Valeria
    Giamporcaro, Silvia
    Conticello, Concetta
    Romano, Alessandra
    Parisi, Marina
    Giuffrida, Gaetano
    Tibullo, Daniele
    Di Raimondo, Francesco
    Santo Signorelli, Salvatore
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 14
  • [35] A RETROSPECTIVE OBSERVATIONAL STUDY OF IBRUTINIB IN REAL-LIFE SETTINGS IN FRANCE, USING THE SNDS DATABASE (OSIRIS)
    de Pouvourville, G.
    Choquet, S.
    Marchal, C.
    Belhassen, M.
    Jacoud, F.
    Guilmet, C.
    Dupuis, S.
    Pierres, M.
    Levy, V
    VALUE IN HEALTH, 2022, 25 (01) : S81 - S82
  • [36] Insulin resistance and metabolic risk related to second-generation antipsychotics in antipsychotic-naive pediatric and adult patients
    Diaz-Caneja, C.
    Pina-Camacho, L.
    Corripio, I.
    Gonzalez-Pinto, A.
    Sanjuan, J.
    Arias, B.
    Saiz, P.
    Garcia, A.
    Jimenez-Arriero, M. A.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S430 - S430
  • [37] Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
    Azekawa, Takaharu
    Ohashi, Shizuko
    Itami, Akira
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 691 - 695
  • [38] Fat Distribution in Schizophrenia Patients A Pilot Study Comparing First- and Second-Generation Antipsychotics
    Sapra, Mamta
    Lawson, Donna
    Iranmanesh, Ali
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (01) : 68 - 71
  • [39] Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study
    L. Malandain
    M. Leygues
    F. Thibaut
    European Archives of Psychiatry and Clinical Neuroscience, 2022, 272 : 583 - 590
  • [40] Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study
    Malandain, L.
    Leygues, M.
    Thibaut, F.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2022, 272 (04) : 583 - 590
12345